• "Purple-Xed" by a baffling bleed - A clinical care conundrum
• A case of disseminated angiosarcoma-like Kaposi sarcoma presenting with unusual vesiculobullous lesions
• A case of pseudo-Kaposi sarcoma with chronic limb-threatening ischemia
• A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus
• A Comparative Review of Standardized Incidence Ratios of De Novo Malignancies Post Liver Transplantation in Males Versus Females
• A Perplexing Purple Rash
• A rare case report of hemophagocytic lymphohistiocytosis secondary to pure eythroid leukemia in a person living with HIV
• A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
• Acquired Immunodeficiency Syndrome (AIDS)-Related Kaposi's Sarcoma in Conjunction With Methicillin-Resistant Staphylococcus aureus (MRSA) and May-Thurner Syndrome
• Advanced HIV disease and associated factors among young people aged 15-24 years at a tertiary hospital in Sierra Leone: a cross-sectional study
• An atlas of chromatin landscape in KSHV-infected cells during de novo infection and reactivation
• Applications of cell therapy in the treatment of virus-associated cancers
• Association between human herpesvirus 8 and lipid profile in northwest China: A cross-sectional study
• Association between KSHV-Specific Humoral and T Cell Responses with Recurrence of HIV-Associated Kaposi Sarcoma
• Biologically significant interaction of human herpesvirus 8 viral interferon regulatory factor 4 with ubiquitin-specific protease 7
• Bullous Kaposi Sarcoma: An Uncommon Blistering Variant in an HIV-Negative Patient
• Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda from 2007 to 2018
• Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis
• Cellular Transformation by Human Cytomegalovirus
• Classic Kaposi Sarcoma in an Immunocompetent Male From Haiti: An Unusual Epidemiological Presentation
• Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly
• Clinical efficacy of the HIV protease-inhibitor Indinavir in combination with chemotherapy for advanced classic Kaposi's sarcoma treatment: a single-arm, phase II trial in the elderly
• Clinicopathological concordance of mucocutaneous manifestations in people living with HIV: A cross-sectional study
• Combined Flow-Fluorescence in situ hybridization to HHV-8 and EBV reveals the viral heterogeneity of primary effusion lymphoma
• Comparison of IL-6, IL-10, and TNFalpha levels between PLWHIV with and without Kaposi Sarcoma and healthy controls
• Conserved cysteine residues in Kaposi's sarcoma herpesvirus ORF34 are necessary for viral production and viral pre-initiation complex formation
• Correction: BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated
• Correction: Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development
• Cytokine Dynamics and Herpesvirus Interactions in Pediatric Liver and Kidney Transplant Recipients: The Distinct Behavior of HCMV, HHV6, HHV7 and EBV
• Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data
• Diffuse gingival hypertrophied Kaposi sarcoma as an initial presentation of HIV Infection
• Discovery of a small-molecule inhibitor of KSHV lytic replication from the MMV pandemic response box
• Disseminated AIDS-associated Kaposi sarcoma without cutaneous involvement: a case report and review of literature
• Disseminated Kaposi sarcoma without primary cutaneous involvement in a kidney transplant recipient
• Effectiveness of community-based hypertension management on hypertension in the urban slums of Haiti: A mixed methods study
• Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient
• Estimating regional and national cancer incidence in Uganda: a retrospective population-based study, 2013-2017
• Evaluation of two commercial diagnostic methods for HHV-8 viral load assessment
• Exacerbation of Kaposi sarcoma following BRAF/MEK inhibitor therapy in a melanoma patient: a case report and mechanistic insight
• Exploring the interplay between Kaposi's sarcoma and SARS-CoV-2 infection: A case series and systematic review
• Gammaherpesvirus infection triggers the formation of tRNA fragments from premature tRNAs
• HHV-8 Linked to Kaposi's Sarcoma and Castleman's Disease in HIV-1-infected patient: Case Report and Review of the Literature
• HHV-8-associated diseases in transplantation: A case report and narrative review focused on diagnosis and prevention
• High malignancy rate in the absence of viral prophylaxis after kidney transplantation in Sudan
• High-density resolution of the Kaposi's sarcoma associated herpesvirus transcriptome identifies novel transcript isoforms generated by long-range transcription and alternative splicing
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
• Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications
• Immune Deficiency/Dysregulation Associated Lymphoid Proliferations, EBV+ In Persons Living With HIV
• Impact of a multicomponent navigation strategy on stigma among people living with HIV and Kaposi's sarcoma in Kenya: a qualitative analysis
• Inflammasome activation in patients with Kaposi sarcoma herpesvirus (KSHV)-associated disorders
• K(v)1.3-induced hyperpolarization is required for efficient Kaposi's sarcoma-associated herpesvirus lytic replication
• Kaposi sarcoma in a men-who-have-sex-with-men patient without human immunodeficiency virus who was treated with upadacitinib for ulcerative colitis
• Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection in vitro or in vivo
• Kaposi's sarcoma
• Kaposi's sarcoma herpesvirus viral FLICE inhibitory protein modulates A20 deubiquitinase activity
• KSHV infection of B cells primes protective T cell responses in humanized mice
• KSHV/HHV-8-associated multicentric Castleman disease and nodal Kaposi sarcoma displaying a lymphangiectatic pattern
• Lactylation of NAT10 promotes N⁴-acetylcytidine modification on tRNA^Ser-CGA-1-1 to boost oncogenic DNA virus KSHV reactivation
• Many faces of cutaneous leishmaniasis
• Mechanisms of <em>Tripterygium wilfordii</em> Hook F on treating rheumatoid arthritis explored by network pharmacology analysis and molecular docking
• Mesenchymal neoplasms of the tongue: A clinicopathologic study of 93 cases
• miR-769-3p inhibits cellular proliferation of KSHV-infected SH-SY5Y cells through targeting mTOR
• Molecular Epidemiology of Isoniazid-resistant <em>M tuberculosis</em> in Port-au-Prince, Haiti
• Molecular mechanisms of human papilloma virus related skin cancers: A review
• Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies
• Neighborhood Social Vulnerability and Premature Cardiovascular Disease in Haiti
• Opportunistic Infections and Malignancies in a Patient With HIV/AIDS and a Critically Low CD4 Count of 1 Cell/μL
• Otorhinolaryngological Manifestations among People Living with HIV/AIDS in Dar es Salaam, Tanzania: a Cross-Sectional Study
• PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma
• People living with HIV co-infected with the Kaposi Sarcoma-associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma
• Pleural Kaposi Sarcoma in Two HIV-Positive Patients
• Pneumothorax Secondary to Cavitating Pulmonary Kaposi Sarcoma in an Immunocompetent Adult
• Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income Countries
• Predictors of Clinical Outcomes among People with HIV and Tuberculosis Symptoms after Rapid Treatment Initiation in Haiti
• Prevalence of anal high-risk human papillomavirus (HR-HPV) types in people living with HIV and a history of cancer
• Primary Classic Penile Kaposi's Sarcoma in a Middle Age Circumcised HIV-Negative Patient: Presentation of an Unusual Case
• Prognostic factors in Kaposi sarcoma, single centre experience
• Promising immunotherapeutic approaches for primary effusion lymphoma
• Pseudo-Kaposi's sarcoma of the left lower extremity after endovascular catheterization for abdominal aortic aneurysm
• Pulmonary Kaposi sarcoma in a patient with bilateral lung transplant: An unexpected diagnosis on transbronchial fine needle aspiration and core biopsy
• Rapid, equipment-free extraction of DNA from skin biopsies for point-of-care diagnostics
• Reply to: Differential diagnosis between Kaposi sarcoma-associated herpesvirus cytokine syndrome and hemophagocytic lymphohistiocytosis
• Retrospective Single-Center Case Study of Clinical Variables and the Degree of Actinic Elastosis Associated with Rare Skin Cancers
• Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance
• Sign of Leser-Trelat Associated with Kaposi Sar-coma in an Immunocompetent Man
• Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma
• Single-Cell Transcriptomic Analysis of Kaposi Sarcoma
• Structures of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus virions reveal species-specific tegument and envelope features
• The cellular Notch1 protein promotes KSHV reactivation in an Rta-dependent manner
• The general transcription factor TFIIB is a target for transcriptome control during cellular stress and viral infection
• The impact of DNA tumor viruses in low-to-middle income countries (LMICS): A literature review
• The Interplay between KSHV Infection and DNA-Sensing Pathways
• The nucleic acid binding protein SFPQ represses EBV lytic reactivation by promoting histone H1 expression
• The risk of developing Kaposi sarcoma after a primary malignancy: A surveillance, epidemiology and end results-based analysis
• The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods
• Topical Sirolimus 0.1% as Off-Label Treatment of Kaposi's Sarcoma
• TRPS1 Expression Is Frequently Seen in a Subset of Cutaneous Mesenchymal Neoplasms and Tumors of Uncertain Differentiation: A Potential Diagnostic Pitfall
• Unanticipated Findings with Upadacitinib Therapy
• Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiation
• Vascular Conjunctival Lesion in a Patient With a Recent Diagnosis of HIV Infection